Nova MSC Berhad Valuation
Is NOVAMSC-PA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NOVAMSC-PA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate NOVAMSC-PA's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate NOVAMSC-PA's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NOVAMSC-PA?
Other financial metrics that can be useful for relative valuation.
What is NOVAMSC-PA's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | RM 258.57m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 7.9x |
Enterprise Value/EBITDA | -94.5x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does NOVAMSC-PA's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 6.6x | ||
SYSTECH Systech Bhd | 8.2x | n/a | RM 241.0m |
CUSCAPI Cuscapi Berhad | 9.7x | n/a | RM 217.3m |
N2N N2N Connect Berhad | 2.5x | n/a | RM 307.0m |
EFORCE Excel Force MSC Berhad | 6x | n/a | RM 195.2m |
NOVAMSC-PA Nova MSC Berhad | 7.1x | n/a | RM 258.6m |
Price-To-Sales vs Peers: NOVAMSC-PA is expensive based on its Price-To-Sales Ratio (7.1x) compared to the peer average (6.6x).
Price to Earnings Ratio vs Industry
How does NOVAMSC-PA's PE Ratio compare vs other companies in the MY Software Industry?
Price-To-Sales vs Industry: NOVAMSC-PA is expensive based on its Price-To-Sales Ratio (7.1x) compared to the MY Software industry average (4x).
Price to Sales Ratio vs Fair Ratio
What is NOVAMSC-PA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 7.1x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate NOVAMSC-PA's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.